JUDr. Vladimír Kremlík
HLAS SAMOSPRÁV
Twitter
AKTIVNÍ
Obsah příspěvku
Due to secondary infections during COVID-19, antimicrobial resistance (AMR) is on the rise, and some infections are increasingly untreatable. The biopharmaceutical industry continues R&D against this threat but reforms are needed to address this challenge head on.
Screenshot
Screenshot není k dispozici
Metadata
| Platforma | Twitter (social) |
| Publikováno | 21.07.2022 17:17 |
| První viděn | 12.04.2026 07:53 |
| Poslední kontrola | 21.04.2026 18:50 |
| Počet slov | 0 |
| Hlídač ID | 00f67bf2a603dc63a010bd9d21ae8b90 |
| Original ID | 1550168126842671104 |
| Zdrojová URL | https://twitter.com/KremlikVladimir/status/1550168126842671104 |